BÖLÜM 6.3 • HİPOGONADİZM
KAYNAKLAR
1. Lee PA, Houk CP. Puberty and its disorders (vol2) In Lifshitz F(eds)
Pediatric Endocrinology (5th ed) NewYork:Informa Healthcare
2007; 290-300
2. Styne DM. The testes. Disorders of sexual differentiatism and puberty in male. In:Pediatric Endocrinology. Sperling MA(ed). Saunders, Philadelphia. 2002, 565-628.
3. Rosenfeld RL. Puberty in female and its disorders. In:Pediatric Endocrinology. Sperling MA(ed). Saunders, Philadelphia. 2002, 445518.
4. Bundak R, Darendeliler F, Günöz H, Baş F, Saka N, Neyzi O. Puberty and pubertal growth in healthy Turkish girls: no evidence for
secular trend. J Clin Res Pediatr Endocrinol. 2008;1(1):8-14.
5. Semiz S, Kurt F, Kurt DT, Zencir M, Sevinç O. Pubertal development
of Turkish children. J Pediatr Endocrinol Metab. 2008;21(10):95161.
6. Achermann JC. Delayed Puberty In Pescovitz OH, Eugster EA(Eds)
Pediatric Endocrinology Mechanisms, Manifestations and Management Philedelphia: Lippincott Williams and Wilkins 2004; 334-349.
7. Heinrichs C. Normal puberty and delayed puberty. Rev Med Brux.
2011;32(4):256-62.
8. Fichna P, Fichna M, Zurawek M, Nowak J. Hypogonadotropic hypogonadism due to GnRH receptor mutation in a sibling. Endokrynol Pol. 2011;62(3):264-7.
9. Hardelin JP, Dode C. The complex genetics of Kallman syndrome:
KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sex Dev 2008; 2:
181–193.
10. Semple RK, Topaloglu AK. The recent genetics of hypogonadotropic hypogonadism — novel insights and new questions. Clin Endcorniol (Oxf) 2010; 72: 427–435.
11. Guran T, Tolhurst G, Bereket A, Rocha N, Porter K, Turan S, Gribble FM, Kotan LD, Akcay T, Atay Z, Canan H, Serin A, O’Rahilly
S, Reimann F, Semple RK, Topaloglu AK. Hypogonadotropic hypogonadism due to a novel missense mutation in the first extracellular loop of the neurokinin B receptor. J Clin Endocrinol Metab.
2009;94(10):3633-9.
12. Topaloglu AK, Kotan LD Molecular causes of hypogonadotropic
hypogonadism. Curr Opin Obstet Gynecol. 2010;22(4):264-70.
13. Canto P, Munguía P, Söderlund D, Castro JJ, Méndez JP. Genetic
analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1. J Androl 2009;30:41–5.
14. Raivio T, Falardeau J, Dwyer A, et al. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med 2007;357:863–73.
15. Caronia LM, Martin C, Welt CK, et al. A genetic basis for functional
hypothalamic amenorrhea. N Engl J Med. 2011 20;364(3):215-25.
16. Bianco SD, Kaiser UB. The genetic and molecular basis of idiopathic
hypogonadotropic hypogonadism. Nat Rev Endocrinol 2009;5:569–
76.
17. Achermann JC, Weiss J, Lee EJ, Jameson JL. Inherited disorders of
the gonadotropin hormones. Mol Cell Endocrinol. 2001 20;179(12):89-96.
18. Zhao L, Bakke M, Krimkevich Y, et al. Steroidogenic factor 1 (SF1)
is essential for pituitary gonadotrope function. Development.
2001;128(2):147-54.
177
19. Jeyasuria P, Ikeda Y, Jamin SP, et al. Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol
Endocrinol. 2004;18(7):1610-9.
20. Jadhav U, Harris RM, Jameson JL. Hypogonadotropic hypogonadism in subjects with DAX1 mutations. Mol Cell Endocrinol. 2011
22;346(1-2):65-73.
21. Wu CM, Zhang HB, Zhou Q, et al. Two novel DAX1 gene mutations in Chinese patients with X-linked adrenal hypoplasia